by MCT | Oct 15, 2020 | Uncategorized
With the rather discouraging announcement by Johnson & Johnson and Eli Lilly that enrolment for its COVID19 antibody treatment has been paused due to one participant having developed an “adverse reaction,” many people have grown curious about the entire clinical...
by MCT | Oct 2, 2020 | Uncategorized
Not everyone qualifies for paid clinical trials in California. For example, there are people out there who may be adversely affected by the medicines or treatments they will be receiving during certain trials. People who have weakened immune systems are often excluded...
by MCT | Sep 25, 2020 | Uncategorized
With all the news surrounding COVID-19 and clinical trials on a coronavirus vaccine, we thought it fitting to discuss the importance of clinical trials. Why do we need clinical trials and what is the importance of the medical research institutes that conduct these...
by MCT | Sep 21, 2020 | Uncategorized
There is a rather bleak fact about clinical trials – there are delays for up to 80% of cases. However, there are solutions to the most common patient recruitment challenges that can help accelerate much needed trials. Here, we list some of the challenges to patient...
by MCT | Aug 28, 2020 | Uncategorized
According to the latest industry research, about 90 percent of drugs that reach clinical stage development never make it to FDA approval. Although that figure might alarm the general public, scientists are all too very familiar with this fact. Since clinical trials do...
